YOSEMITE PATHOLOGY MEDICAL GROUP, INC. has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan YOSEMITE PATHOLOGY MEDICAL GRP 401(K)
| Measure | Date | Value |
|---|
| 2023: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2023 401k membership |
|---|
| Total participants, beginning-of-year | 2023-04-01 | 169 |
| Total number of active participants reported on line 7a of the Form 5500 | 2023-04-01 | 139 |
| Number of retired or separated participants receiving benefits | 2023-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2023-04-01 | 40 |
| Total of all active and inactive participants | 2023-04-01 | 179 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2023-04-01 | 0 |
| Total participants | 2023-04-01 | 179 |
| Number of participants with account balances | 2023-04-01 | 129 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2023-04-01 | 0 |
| 2022: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2022 401k membership |
|---|
| Total participants, beginning-of-year | 2022-04-01 | 168 |
| Total number of active participants reported on line 7a of the Form 5500 | 2022-04-01 | 133 |
| Number of retired or separated participants receiving benefits | 2022-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2022-04-01 | 27 |
| Total of all active and inactive participants | 2022-04-01 | 160 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-04-01 | 0 |
| Total participants | 2022-04-01 | 160 |
| Number of participants with account balances | 2022-04-01 | 120 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-04-01 | 0 |
| 2021: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2021 401k membership |
|---|
| Total participants, beginning-of-year | 2021-04-01 | 119 |
| Total number of active participants reported on line 7a of the Form 5500 | 2021-04-01 | 121 |
| Number of retired or separated participants receiving benefits | 2021-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2021-04-01 | 27 |
| Total of all active and inactive participants | 2021-04-01 | 148 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-04-01 | 0 |
| Total participants | 2021-04-01 | 148 |
| Number of participants with account balances | 2021-04-01 | 119 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-04-01 | 0 |
| 2020: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2020 401k membership |
|---|
| Total participants, beginning-of-year | 2020-04-01 | 119 |
| Total number of active participants reported on line 7a of the Form 5500 | 2020-04-01 | 95 |
| Number of retired or separated participants receiving benefits | 2020-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2020-04-01 | 19 |
| Total of all active and inactive participants | 2020-04-01 | 114 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-04-01 | 0 |
| Total participants | 2020-04-01 | 114 |
| Number of participants with account balances | 2020-04-01 | 108 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-04-01 | 0 |
| 2019: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2019 401k membership |
|---|
| Total participants, beginning-of-year | 2019-04-01 | 119 |
| Total number of active participants reported on line 7a of the Form 5500 | 2019-04-01 | 94 |
| Number of retired or separated participants receiving benefits | 2019-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2019-04-01 | 21 |
| Total of all active and inactive participants | 2019-04-01 | 115 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-04-01 | 0 |
| Total participants | 2019-04-01 | 115 |
| Number of participants with account balances | 2019-04-01 | 99 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-04-01 | 0 |
| 2018: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2018 401k membership |
|---|
| Total participants, beginning-of-year | 2018-04-01 | 119 |
| Total number of active participants reported on line 7a of the Form 5500 | 2018-04-01 | 96 |
| Number of retired or separated participants receiving benefits | 2018-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2018-04-01 | 20 |
| Total of all active and inactive participants | 2018-04-01 | 116 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-04-01 | 0 |
| Total participants | 2018-04-01 | 116 |
| Number of participants with account balances | 2018-04-01 | 94 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-04-01 | 0 |
| 2017: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2017 401k membership |
|---|
| Total participants, beginning-of-year | 2017-04-01 | 108 |
| Total number of active participants reported on line 7a of the Form 5500 | 2017-04-01 | 91 |
| Number of retired or separated participants receiving benefits | 2017-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2017-04-01 | 25 |
| Total of all active and inactive participants | 2017-04-01 | 116 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-04-01 | 0 |
| Total participants | 2017-04-01 | 116 |
| Number of participants with account balances | 2017-04-01 | 89 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-04-01 | 0 |
| 2016: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2016 401k membership |
|---|
| Total participants, beginning-of-year | 2016-04-01 | 101 |
| Total number of active participants reported on line 7a of the Form 5500 | 2016-04-01 | 79 |
| Number of retired or separated participants receiving benefits | 2016-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2016-04-01 | 19 |
| Total of all active and inactive participants | 2016-04-01 | 98 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2016-04-01 | 0 |
| Total participants | 2016-04-01 | 98 |
| Number of participants with account balances | 2016-04-01 | 79 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2016-04-01 | 0 |
| 2015: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2015 401k membership |
|---|
| Total participants, beginning-of-year | 2015-04-01 | 85 |
| Total number of active participants reported on line 7a of the Form 5500 | 2015-04-01 | 80 |
| Number of retired or separated participants receiving benefits | 2015-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2015-04-01 | 14 |
| Total of all active and inactive participants | 2015-04-01 | 94 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2015-04-01 | 0 |
| Total participants | 2015-04-01 | 94 |
| Number of participants with account balances | 2015-04-01 | 76 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2015-04-01 | 1 |
| 2014: YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2014 401k membership |
|---|
| Total participants, beginning-of-year | 2014-04-01 | 80 |
| Total number of active participants reported on line 7a of the Form 5500 | 2014-04-01 | 72 |
| Number of retired or separated participants receiving benefits | 2014-04-01 | 0 |
| Number of other retired or separated participants entitled to future benefits | 2014-04-01 | 11 |
| Total of all active and inactive participants | 2014-04-01 | 83 |
| Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2014-04-01 | 0 |
| Total participants | 2014-04-01 | 83 |
| Number of participants with account balances | 2014-04-01 | 64 |
| Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2014-04-01 | 0 |
| Measure | Date | Value |
|---|
| 2023 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $2,478,278 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $346,163 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $294,036 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $1,135,626 |
| Value of total assets at end of year | 2023-12-31 | $15,858,106 |
| Value of total assets at beginning of year | 2023-12-31 | $13,725,991 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $52,127 |
| Total interest from all sources | 2023-12-31 | $37,345 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $118,967 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $118,967 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $739,054 |
| Participant contributions at end of year | 2023-12-31 | $332,665 |
| Participant contributions at beginning of year | 2023-12-31 | $356,140 |
| Participant contributions at end of year | 2023-12-31 | $37,222 |
| Participant contributions at beginning of year | 2023-12-31 | $18,109 |
| Assets. Other investments not covered elsewhere at end of year | 2023-12-31 | $7,299,940 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-12-31 | $6,091,958 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $8,325 |
| Other income not declared elsewhere | 2023-12-31 | $752,941 |
| Administrative expenses (other) incurred | 2023-12-31 | $10,285 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $2,132,115 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $15,858,106 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $13,725,991 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Investment advisory and management fees | 2023-12-31 | $28,579 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $5,522,138 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $4,805,445 |
| Value of interest in pooled separate accounts at end of year | 2023-12-31 | $449,492 |
| Value of interest in pooled separate accounts at beginning of year | 2023-12-31 | $392,076 |
| Interest on participant loans | 2023-12-31 | $16,653 |
| Interest earned on other investments | 2023-12-31 | $20,692 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $1,756,779 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $1,545,213 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $378,631 |
| Net investment gain/loss from pooled separate accounts | 2023-12-31 | $54,768 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $388,247 |
| Employer contributions (assets) at end of year | 2023-12-31 | $459,870 |
| Employer contributions (assets) at beginning of year | 2023-12-31 | $517,050 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $294,036 |
| Contract administrator fees | 2023-12-31 | $13,263 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | BOWMAN & COMPNAY |
| Accountancy firm EIN | 2023-12-31 | 941481988 |
| Total unrealized appreciation/depreciation of assets | 2023-04-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-04-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-04-01 | $0 |
| Total income from all sources (including contributions) | 2023-04-01 | $2,478,278 |
| Total loss/gain on sale of assets | 2023-04-01 | $0 |
| Total of all expenses incurred | 2023-04-01 | $346,163 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-04-01 | $294,036 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-04-01 | $1,135,626 |
| Value of total assets at end of year | 2023-04-01 | $15,858,106 |
| Value of total assets at beginning of year | 2023-04-01 | $13,725,991 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-04-01 | $52,127 |
| Total interest from all sources | 2023-04-01 | $37,345 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-04-01 | $118,967 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-04-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-04-01 | $118,967 |
| Was this plan covered by a fidelity bond | 2023-04-01 | Yes |
| Value of fidelity bond cover | 2023-04-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-04-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-04-01 | No |
| Contributions received from participants | 2023-04-01 | $739,054 |
| Participant contributions at end of year | 2023-04-01 | $332,665 |
| Participant contributions at beginning of year | 2023-04-01 | $356,140 |
| Participant contributions at end of year | 2023-04-01 | $37,222 |
| Participant contributions at beginning of year | 2023-04-01 | $18,109 |
| Assets. Other investments not covered elsewhere at end of year | 2023-04-01 | $7,299,940 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-04-01 | $6,091,958 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-04-01 | $8,325 |
| Other income not declared elsewhere | 2023-04-01 | $752,941 |
| Administrative expenses (other) incurred | 2023-04-01 | $10,285 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-04-01 | No |
| Value of net income/loss | 2023-04-01 | $2,132,115 |
| Value of net assets at end of year (total assets less liabilities) | 2023-04-01 | $15,858,106 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-04-01 | $13,725,991 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-04-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-04-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-04-01 | No |
| Investment advisory and management fees | 2023-04-01 | $28,579 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-04-01 | $5,522,138 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-04-01 | $4,805,445 |
| Value of interest in pooled separate accounts at end of year | 2023-04-01 | $449,492 |
| Value of interest in pooled separate accounts at beginning of year | 2023-04-01 | $392,076 |
| Interest on participant loans | 2023-04-01 | $16,653 |
| Interest earned on other investments | 2023-04-01 | $20,692 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-04-01 | $1,756,779 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-04-01 | $1,545,213 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-04-01 | $378,631 |
| Net investment gain/loss from pooled separate accounts | 2023-04-01 | $54,768 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-04-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-04-01 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2023-04-01 | No |
| Contributions received in cash from employer | 2023-04-01 | $388,247 |
| Employer contributions (assets) at end of year | 2023-04-01 | $459,870 |
| Employer contributions (assets) at beginning of year | 2023-04-01 | $517,050 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-04-01 | $294,036 |
| Contract administrator fees | 2023-04-01 | $13,263 |
| Did the plan have assets held for investment | 2023-04-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-04-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-04-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-04-01 | 1 |
| Accountancy firm name | 2023-04-01 | BOWMAN & COMPNAY |
| Accountancy firm EIN | 2023-04-01 | 941481988 |
| Total unrealized appreciation/depreciation of assets | 2023-03-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-03-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-03-31 | $0 |
| Total income from all sources (including contributions) | 2023-03-31 | $627,907 |
| Total loss/gain on sale of assets | 2023-03-31 | $0 |
| Total of all expenses incurred | 2023-03-31 | $268,994 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-03-31 | $214,724 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-03-31 | $1,455,770 |
| Value of total assets at end of year | 2023-03-31 | $13,725,114 |
| Value of total assets at beginning of year | 2023-03-31 | $13,366,201 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-03-31 | $54,270 |
| Total interest from all sources | 2023-03-31 | $45,558 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-03-31 | $135,048 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-03-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-03-31 | $135,048 |
| Administrative expenses professional fees incurred | 2023-03-31 | $12,209 |
| Was this plan covered by a fidelity bond | 2023-03-31 | Yes |
| Value of fidelity bond cover | 2023-03-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-03-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-03-31 | No |
| Contributions received from participants | 2023-03-31 | $950,470 |
| Participant contributions at end of year | 2023-03-31 | $340,082 |
| Participant contributions at beginning of year | 2023-03-31 | $395,485 |
| Participant contributions at end of year | 2023-03-31 | $15,609 |
| Participant contributions at beginning of year | 2023-03-31 | $4,179 |
| Assets. Other investments not covered elsewhere at end of year | 2023-03-31 | $6,091,957 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-03-31 | $6,091,842 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-03-31 | $12,557 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-03-31 | $29,739 |
| Other income not declared elsewhere | 2023-03-31 | $-542,692 |
| Administrative expenses (other) incurred | 2023-03-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-03-31 | No |
| Value of net income/loss | 2023-03-31 | $358,913 |
| Value of net assets at end of year (total assets less liabilities) | 2023-03-31 | $13,725,114 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-03-31 | $13,366,201 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-03-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-03-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-03-31 | No |
| Investment advisory and management fees | 2023-03-31 | $26,945 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-03-31 | $4,805,445 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-03-31 | $4,559,457 |
| Value of interest in pooled separate accounts at end of year | 2023-03-31 | $392,076 |
| Value of interest in pooled separate accounts at beginning of year | 2023-03-31 | $377,443 |
| Interest on participant loans | 2023-03-31 | $21,397 |
| Interest earned on other investments | 2023-03-31 | $24,161 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-03-31 | $1,545,213 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-03-31 | $1,438,913 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-03-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-03-31 | $-432,153 |
| Net investment gain/loss from pooled separate accounts | 2023-03-31 | $-33,624 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-03-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-03-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-03-31 | No |
| Contributions received in cash from employer | 2023-03-31 | $492,743 |
| Employer contributions (assets) at end of year | 2023-03-31 | $504,993 |
| Employer contributions (assets) at beginning of year | 2023-03-31 | $498,882 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-03-31 | $214,724 |
| Contract administrator fees | 2023-03-31 | $15,116 |
| Did the plan have assets held for investment | 2023-03-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-03-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-03-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-03-31 | Unqualified |
| Accountancy firm name | 2023-03-31 | BOWMAN & COMPANY LLC |
| Accountancy firm EIN | 2023-03-31 | 941481988 |
| 2022 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-04-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-04-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-04-01 | $0 |
| Total income from all sources (including contributions) | 2022-04-01 | $912,364 |
| Total loss/gain on sale of assets | 2022-04-01 | $0 |
| Total of all expenses incurred | 2022-04-01 | $268,994 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-04-01 | $214,724 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-04-01 | $1,455,780 |
| Value of total assets at end of year | 2022-04-01 | $13,725,991 |
| Value of total assets at beginning of year | 2022-04-01 | $13,082,621 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-04-01 | $54,270 |
| Total interest from all sources | 2022-04-01 | $46,713 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-04-01 | $135,048 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-04-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-04-01 | $135,048 |
| Administrative expenses professional fees incurred | 2022-04-01 | $12,209 |
| Was this plan covered by a fidelity bond | 2022-04-01 | Yes |
| Value of fidelity bond cover | 2022-04-01 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-04-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-04-01 | No |
| Contributions received from participants | 2022-04-01 | $950,480 |
| Participant contributions at end of year | 2022-04-01 | $356,140 |
| Participant contributions at beginning of year | 2022-04-01 | $406,747 |
| Participant contributions at end of year | 2022-04-01 | $18,109 |
| Participant contributions at beginning of year | 2022-04-01 | $15,033 |
| Assets. Other investments not covered elsewhere at end of year | 2022-04-01 | $6,091,958 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-04-01 | $5,774,089 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-04-01 | $12,557 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-04-01 | $29,739 |
| Other income not declared elsewhere | 2022-04-01 | $-259,399 |
| Administrative expenses (other) incurred | 2022-04-01 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-04-01 | No |
| Value of net income/loss | 2022-04-01 | $643,370 |
| Value of net assets at end of year (total assets less liabilities) | 2022-04-01 | $13,725,991 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-04-01 | $13,082,621 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-04-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-04-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-04-01 | No |
| Investment advisory and management fees | 2022-04-01 | $26,945 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-04-01 | $4,805,445 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-04-01 | $4,559,457 |
| Value of interest in pooled separate accounts at end of year | 2022-04-01 | $392,076 |
| Value of interest in pooled separate accounts at beginning of year | 2022-04-01 | $377,443 |
| Interest on participant loans | 2022-04-01 | $22,552 |
| Interest earned on other investments | 2022-04-01 | $24,161 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-04-01 | $1,545,213 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-04-01 | $1,438,913 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-04-01 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-04-01 | $-432,154 |
| Net investment gain/loss from pooled separate accounts | 2022-04-01 | $-33,624 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-04-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-04-01 | Yes |
| Has the plan failed to provide any benefit when due under the plan | 2022-04-01 | No |
| Contributions received in cash from employer | 2022-04-01 | $492,743 |
| Employer contributions (assets) at end of year | 2022-04-01 | $517,050 |
| Employer contributions (assets) at beginning of year | 2022-04-01 | $510,939 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-04-01 | $214,724 |
| Contract administrator fees | 2022-04-01 | $15,116 |
| Did the plan have assets held for investment | 2022-04-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-04-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-04-01 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-04-01 | 1 |
| Accountancy firm name | 2022-04-01 | BOWMAN & COMPANY LLC |
| Accountancy firm EIN | 2022-04-01 | 941481988 |
| Total plan liabilities at end of year | 2022-03-31 | $0 |
| Total income from all sources | 2022-03-31 | $1,659,838 |
| Expenses. Total of all expenses incurred | 2022-03-31 | $1,932,530 |
| Benefits paid (including direct rollovers) | 2022-03-31 | $1,932,530 |
| Total plan assets at end of year | 2022-03-31 | $13,366,201 |
| Total plan assets at beginning of year | 2022-03-31 | $13,638,893 |
| Value of fidelity bond covering the plan | 2022-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2022-03-31 | $889,152 |
| Expenses. Other expenses not covered elsewhere | 2022-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2022-03-31 | $590 |
| Other income received | 2022-03-31 | $283,464 |
| Net income (gross income less expenses) | 2022-03-31 | $-272,692 |
| Net plan assets at end of year (total assets less liabilities) | 2022-03-31 | $13,366,201 |
| Net plan assets at beginning of year (total assets less liabilities) | 2022-03-31 | $13,638,893 |
| Assets. Value of participant loans | 2022-03-31 | $395,485 |
| Assets. Value of real-estate (other than employer real property) | 2022-03-31 | $0 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2022-03-31 | $6,095 |
| Total contributions received or receivable from employer(s) | 2022-03-31 | $486,632 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2022-03-31 | $0 |
| 2021 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2021 401k financial data |
|---|
| Total income from all sources | 2021-03-31 | $5,220,992 |
| Expenses. Total of all expenses incurred | 2021-03-31 | $2,747,926 |
| Benefits paid (including direct rollovers) | 2021-03-31 | $2,686,479 |
| Total plan assets at end of year | 2021-03-31 | $13,638,893 |
| Total plan assets at beginning of year | 2021-03-31 | $11,165,827 |
| Value of fidelity bond covering the plan | 2021-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2021-03-31 | $806,212 |
| Expenses. Other expenses not covered elsewhere | 2021-03-31 | $54,318 |
| Contributions received from other sources (not participants or employers) | 2021-03-31 | $1,136,827 |
| Other income received | 2021-03-31 | $2,865,679 |
| Net income (gross income less expenses) | 2021-03-31 | $2,473,066 |
| Net plan assets at end of year (total assets less liabilities) | 2021-03-31 | $13,638,893 |
| Net plan assets at beginning of year (total assets less liabilities) | 2021-03-31 | $11,165,827 |
| Assets. Value of participant loans | 2021-03-31 | $291,756 |
| Assets. Value of real-estate (other than employer real property) | 2021-03-31 | $526,200 |
| Total contributions received or receivable from employer(s) | 2021-03-31 | $412,274 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2021-03-31 | $7,129 |
| 2020 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2020 401k financial data |
|---|
| Total income from all sources | 2020-03-31 | $543,508 |
| Expenses. Total of all expenses incurred | 2020-03-31 | $3,393,337 |
| Benefits paid (including direct rollovers) | 2020-03-31 | $3,334,670 |
| Total plan assets at end of year | 2020-03-31 | $11,165,827 |
| Total plan assets at beginning of year | 2020-03-31 | $14,015,656 |
| Value of fidelity bond covering the plan | 2020-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2020-03-31 | $680,157 |
| Expenses. Other expenses not covered elsewhere | 2020-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2020-03-31 | $197,894 |
| Other income received | 2020-03-31 | $-700,415 |
| Net income (gross income less expenses) | 2020-03-31 | $-2,849,829 |
| Net plan assets at end of year (total assets less liabilities) | 2020-03-31 | $11,165,827 |
| Net plan assets at beginning of year (total assets less liabilities) | 2020-03-31 | $14,015,656 |
| Assets. Value of participant loans | 2020-03-31 | $309,850 |
| Assets. Value of real-estate (other than employer real property) | 2020-03-31 | $598,000 |
| Total contributions received or receivable from employer(s) | 2020-03-31 | $365,872 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2020-03-31 | $58,667 |
| 2019 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2019 401k financial data |
|---|
| Total income from all sources | 2019-03-31 | $884,575 |
| Expenses. Total of all expenses incurred | 2019-03-31 | $2,175,689 |
| Benefits paid (including direct rollovers) | 2019-03-31 | $2,175,689 |
| Total plan assets at end of year | 2019-03-31 | $14,015,656 |
| Total plan assets at beginning of year | 2019-03-31 | $15,306,770 |
| Value of fidelity bond covering the plan | 2019-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2019-03-31 | $613,600 |
| Expenses. Other expenses not covered elsewhere | 2019-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2019-03-31 | $8,153 |
| Other income received | 2019-03-31 | $-42,426 |
| Net income (gross income less expenses) | 2019-03-31 | $-1,291,114 |
| Net plan assets at end of year (total assets less liabilities) | 2019-03-31 | $14,015,656 |
| Net plan assets at beginning of year (total assets less liabilities) | 2019-03-31 | $15,306,770 |
| Assets. Value of participant loans | 2019-03-31 | $309,752 |
| Assets. Value of real-estate (other than employer real property) | 2019-03-31 | $918,642 |
| Total contributions received or receivable from employer(s) | 2019-03-31 | $305,248 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2019-03-31 | $0 |
| 2018 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2018 401k financial data |
|---|
| Total income from all sources | 2018-03-31 | $2,455,962 |
| Expenses. Total of all expenses incurred | 2018-03-31 | $2,857,217 |
| Benefits paid (including direct rollovers) | 2018-03-31 | $2,857,217 |
| Total plan assets at end of year | 2018-03-31 | $15,306,770 |
| Total plan assets at beginning of year | 2018-03-31 | $15,708,025 |
| Value of fidelity bond covering the plan | 2018-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2018-03-31 | $567,496 |
| Expenses. Other expenses not covered elsewhere | 2018-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2018-03-31 | $0 |
| Other income received | 2018-03-31 | $1,589,864 |
| Net income (gross income less expenses) | 2018-03-31 | $-401,255 |
| Net plan assets at end of year (total assets less liabilities) | 2018-03-31 | $15,306,770 |
| Net plan assets at beginning of year (total assets less liabilities) | 2018-03-31 | $15,708,025 |
| Assets. Value of participant loans | 2018-03-31 | $341,609 |
| Assets. Value of real-estate (other than employer real property) | 2018-03-31 | $1,250,363 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2018-03-31 | $236 |
| Total contributions received or receivable from employer(s) | 2018-03-31 | $298,602 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2018-03-31 | $0 |
| 2017 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2017 401k financial data |
|---|
| Total income from all sources | 2017-03-31 | $2,105,763 |
| Expenses. Total of all expenses incurred | 2017-03-31 | $249,973 |
| Benefits paid (including direct rollovers) | 2017-03-31 | $249,973 |
| Total plan assets at end of year | 2017-03-31 | $15,708,025 |
| Total plan assets at beginning of year | 2017-03-31 | $13,852,235 |
| Value of fidelity bond covering the plan | 2017-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2017-03-31 | $587,962 |
| Expenses. Other expenses not covered elsewhere | 2017-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2017-03-31 | $0 |
| Other income received | 2017-03-31 | $1,234,213 |
| Net income (gross income less expenses) | 2017-03-31 | $1,855,790 |
| Net plan assets at end of year (total assets less liabilities) | 2017-03-31 | $15,708,025 |
| Net plan assets at beginning of year (total assets less liabilities) | 2017-03-31 | $13,852,235 |
| Assets. Value of participant loans | 2017-03-31 | $399,705 |
| Assets. Value of assets in partnership/joint-venture interests | 2017-03-31 | $74,884 |
| Assets. Value of real-estate (other than employer real property) | 2017-03-31 | $1,173,287 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2017-03-31 | $5,000 |
| Total contributions received or receivable from employer(s) | 2017-03-31 | $283,588 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2017-03-31 | $0 |
| 2016 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2016 401k financial data |
|---|
| Total income from all sources | 2016-03-31 | $171,992 |
| Expenses. Total of all expenses incurred | 2016-03-31 | $4,950,634 |
| Benefits paid (including direct rollovers) | 2016-03-31 | $4,950,634 |
| Total plan assets at end of year | 2016-03-31 | $13,852,235 |
| Total plan assets at beginning of year | 2016-03-31 | $18,630,877 |
| Value of fidelity bond covering the plan | 2016-03-31 | $500,000 |
| Total contributions received or receivable from participants | 2016-03-31 | $449,561 |
| Expenses. Other expenses not covered elsewhere | 2016-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2016-03-31 | $31,114 |
| Other income received | 2016-03-31 | $-542,774 |
| Net income (gross income less expenses) | 2016-03-31 | $-4,778,642 |
| Net plan assets at end of year (total assets less liabilities) | 2016-03-31 | $13,852,235 |
| Net plan assets at beginning of year (total assets less liabilities) | 2016-03-31 | $18,630,877 |
| Assets. Value of participant loans | 2016-03-31 | $339,545 |
| Assets. Value of assets in partnership/joint-venture interests | 2016-03-31 | $17,884 |
| Assets. Value of real-estate (other than employer real property) | 2016-03-31 | $1,173,287 |
| Value of participant contributions where there was a failure to transmit these to the plan within the time period described in 29 CFR 2510.3-102 | 2016-03-31 | $1,103 |
| Total contributions received or receivable from employer(s) | 2016-03-31 | $234,091 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2016-03-31 | $0 |
| 2015 : YOSEMITE PATHOLOGY MEDICAL GRP 401(K) 2015 401k financial data |
|---|
| Transfers to/from the plan | 2015-03-31 | $0 |
| Total income from all sources | 2015-03-31 | $2,116,783 |
| Expenses. Total of all expenses incurred | 2015-03-31 | $160,687 |
| Benefits paid (including direct rollovers) | 2015-03-31 | $160,687 |
| Total plan assets at end of year | 2015-03-31 | $23,150,961 |
| Total plan assets at beginning of year | 2015-03-31 | $21,194,865 |
| Value of fidelity bond covering the plan | 2015-03-31 | $1,200,000 |
| Total contributions received or receivable from participants | 2015-03-31 | $361,121 |
| Assets. Value of loans (other than to participants) | 2015-03-31 | $148,561 |
| Expenses. Other expenses not covered elsewhere | 2015-03-31 | $0 |
| Contributions received from other sources (not participants or employers) | 2015-03-31 | $0 |
| Other income received | 2015-03-31 | $1,554,232 |
| Net income (gross income less expenses) | 2015-03-31 | $1,956,096 |
| Net plan assets at end of year (total assets less liabilities) | 2015-03-31 | $23,150,961 |
| Net plan assets at beginning of year (total assets less liabilities) | 2015-03-31 | $21,194,865 |
| Assets. Value of participant loans | 2015-03-31 | $123,061 |
| Assets. Value of assets in partnership/joint-venture interests | 2015-03-31 | $833,672 |
| Assets. Value of real-estate (other than employer real property) | 2015-03-31 | $339,615 |
| Total contributions received or receivable from employer(s) | 2015-03-31 | $201,430 |
| Expenses. Administrative service providers (salaries,fees and commissions) | 2015-03-31 | $0 |
